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Rats with obstructive pyelonephritis due to Escherichia coli were treated for differ-
ent intervals with ampicillin and gentamicin either alone or in combination. The
combination of ampicillin and gentamicin was synergistic in vitro and significantly
more effective in vivo than was either drug alone. After treatment for 10 days, the
combination of ampicillin and gentamicin was the only regimen that sterilized all of
the pyelonephritic kidneys. The importance of achieving sterility was illustrated by
the observation that severe infection and acute pyelonephritis recurred after religa-
tion of the ureter in 12 (71%) of 17 ampicillin-treated animals that had harbored as
few as 46 organisms per kidney before ligation. A synergistic combination of anti-
biotics rapidly sterilizes obstructed pyelonephritic kidneys. In view of the par-
ticular risk of renal infection in the presence of urinary obstruction in humans,
synergistic antibiotic combinations may be useful in the treatment of obstructive
pyelonephritis in humans.
The emphasis in recent years on noninfectious
causes of interstitial nephritis has minimized the
importance of urinary tract infections in the pres-
ence of obstruction as a cause of serious kid-
ney disease. Nevertheless, infectious pyelonephri-
tis in obstructive renal disease is the second most
common cause of end-stage kidney failure, may
be responsible for 9%-18% of patients who
require dialysis or transplantation [1, 2], and pro-
duces innumerable other cases of unilateral or
severe bilateral kidney damage. We have experi-
mental evidence that destruction of renal paren-
chyma results from injury due to inflammation
and suppuration during acute pyelonephritis
[3]. It is therefore of considerable importance to
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study the way in which antibiotics are most
effective in preventing destruction of the obstruct-
ed infected kidney.
Previous studies of the effectiveness of antibiot-
ic therapy in the treatment of experimentally
induced retrograde kidney infections were not
performed in the presence of renal obstruction,
which is the most important factor in severe
human kidney infections. Furthermore, these
studies were not designed to determine a thera-
peutic regimen that would sterilize the infected
kidneys, and antibiotics were not administered
in dosages that mimicked treatment of human
obstructive pyelonephritis [4-10]. Accordingly,
this study was undertaken to investigate the treat-
ment of acute pyelonephritis due to Escherichia
coli in the rat with the antibiotics, dosages, and
routes of administration commonly used in the
treatment of pyelonephritis in humans.
For these studies, we used a model of acute
experimental pyelonephritis in the rat, which re-
sembled severe human pyelonephritis in that in-
fection of the kidney was acquired by the retro-
grade route in the presence of partial obstruction
[11]. Ampicillin and gentamicin were given alone
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and in combination to see whether in vitro syner-
gism would be reflected in an in vivo response.
Materials and Methods
Bacteria and in vitro susceptibility tests. The
strain of E. coli 06 (Williams) used to infect the
rats has been previously described [II). It is in-
hibited by 2.5 JLg of ampicillin/ml or 1.2 jLg
of gentamicin rml, Bacterial killing was stud-
ied in the following manner: an overnight broth
culture was appropriately diluted in Mueller-
Hinton broth (MHB; Baltimore Biological Lab-
oratories [BBL], Cockeysville, Md.) and added to
50 ml of MHB to give a final concentration of 106
organisrnsrml. Various amounts of ampicillin,
gentamicin, or a combination of the two drugs
were added to the flasks of MHB before the bac-
teria were inoculated. Samples were removed at
different intervals and appropriately diluted in
MHB without antibiotics before 0.5 ml of each
dilution was plated onto Mueller-Hinton agar
plates (BBL) containing 1,000 units of penicil-
linase/ml.
Production of pyelonephritis. Acute retro-
grade pyelonephritis was produced in male Wis-
tar-Lewis rats weighing 225-250 g (Charles
River Breeding Laboratories, Wilmington,
Mass.). Acute retrograde pyelonephritis was in-
duced as described previously [II] with slight
modification. In brief, after the rats were deprived
of water for 18 hr and placed under ether anes-
thesia, a midline incision of the abdominal wall
was made. A 1.0-ml bacterial inoculum of 2 X 103
organisms /ml of an overnight culture of E. coli
06 (Williams) in trypticase soy broth (TSB;
BBL) was gently infused into the bladder. Re-
flux consistently occurred when urine appeared
at the external urethral meatus. The remainder
of the 1.0-ml volume was passed externally
through the urethra without causing further
bladder distension. After the infusion a silk liga-
ture around the left ureter was loosely tied
through the left flank, and the abdominal wall
was closed. The ligature was carefully removed
from the outside 20 hr later. The incidence of
gross pyelonephritis 30 hr after ligation was
-75% as judged by the appearance of numerous
small abscesses on the surface of the kidney. Some
degree of ureteral and pyelic dilatation as well
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as residual hydronephrosis remained throughout
the course of the disease (12).
Treatment with antibiotics. Sodium ampicil-
lin (Bristol Laboratories, Syracuse, N.Y.) (10 mg
in a volume of 0.1 ml or 160 mg/kg per day) was
injected im in alternate thighs at 6-hr intervals.
Gentamicin (Schering, Kenilworth, N.J.) (I mg in
a volume of 0.1 ml or 8 mg/kg per day) was given
at 12-hr intervals since it accumulates in the kid-
ney [13]. Preliminary studies showed that these
dosages would have an approximately equivalent
antimicrobial effect in vivo. Serum levels were de-
termined in five rats after im injection of a single
dose of either drug. Blood was obtained from the
tail by the "farmer's wife" method [14). Serum
levels were measured in a standard manner (15).
The mean levels (JLg/ml) ± SD obtained with
am picillin were 35.5 ± 17.8 at 30 min, 6.5 ± 2.9
at 1 hr, and 1.2 ± 0.5 at 2 hr. The mean levels
(,ug/ml) ± SD of gentamicin were 8.0 ± 2.1 at
30 min, 4.6 ± 1.8 at I hr, and 1.9 ± 0.9 at 2 hr.
For treatment with both antibiotics combined,
the same dosages were used as when each drug
was given alone. Control animals were given 0.1
ml of saline im four times daily. To determine
the importance of the duration of treatment,
the following schedules were used, each begin-
ning 28-30 hr after ligation (numbers in paren-
theses are the number of times each drug was
given; Amp = ampicillin and Gm =gentami-
cin): (1) over 1.5 days, Amp (six), Gm (three),
Amp (six) plus Gm (three), saline (six), (2) over
3.5 days, Amp (14), Gm (seven), Amp (14) plus
Gm (seven), saline (14); (3) over 5.5 days, Amp
(22), Gm (II), Amp (22) plus Gm (II), saline
(22); and (4) over 10 days, Amp (40), Gm (20),
Amp (40) plus Gm (20), saline (40).
Between 24 and 36 rats were operated on at one
time; they were divided into four groups and
treated with the various regimens for various in-
tervals. Each experiment was performed three
times. A few rats in control groups (receiving
saline) died as a result of septicemia between
days 3 and 5 after infection, but none of the treat-
ed animals died.
Effect of treatment with antibiotics on kidney
infection. The effectiveness of therapy was as-
sessed on the basis both of the number of bacteria
present in the kidney and of the severity of pyelo-
nephritis as measured indirectly by kidney weight
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(see below). Only rats showing macroscopic evi-
dence of pyelonephritis (75% of all ligated rats)
were selected for evaluation of the effectiveness
of antibiotic treatment since kidneys without
gross pyelonephritis were uniformly sterile at
each time studied.
At the end of each treatment schedule, the rats
were killed, and the kidneys were removed asepti-
cally, weighed, and homogenized in I ml of TSB.
Tenfold dilutions of the homogenates were
made, and 0.5-ml volumes of the diluted homo-
genates were plated on trypticase soy agar plates
containing 1,000 units of penicillinase rml. The
plates were incubated overnight aerobically at
37 C, and the number of cfu in each plate was
counted. Cultures from animals treated with gen-
tamicin were incubated in anaerobic jars (Gas-
Pak" catalyst; BBL) for 48 hr to decrease the ac-
tivity of gentamicin [16].
Effect of treatment on the course ot pyelone-
phritis. Previous studies using this model of ex-
perimentally induced pyelonephritis have shown
that kidney weight provides the best quantitative
assay of severity of pyelonephritis [12]. During
the acute phase, kidney weight increased in pro-
portion to the degree of inflammation and of
exudation occurring in the renal parenchyma.
To minimize the normal variation in kidney
weights, the ratio of the weight of the left kidney
to that of the right kidney (L/R) was used for
comparison of the severity of pyelonephritis. The
mean ratio is -- I in normal animals and varies
very little (mean ± SD, 0.978 ± 0.03).
Relapse after religation of the left ureter. A
test of residual infection after treatment in the
absence of persistent antibiotic. As demon-
strated by Guze and Beeson [I7], bacteria in a
nonpyelonephritic kidney can cause destructive
pyelonephritis if the ureter is ligated. This phe-
nomenon was used to test the virulence of the
few surviving organisms after therapy with ampi-
cillin or gentamicin. Groups of 16-20 rats were
operated on and treated for IO days with one
of the two antibiotics. Thirty-six hours after com-
pletion of therapy, the animals were either killed
(controls) or operated on again. After rats
were anesthetized with ether, the left kidney was
exposed through a paramedial incision and in-
spected for the presence of pyelonephritic corti-
cal lesions. The left ureter was religated by the
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procedure used in the initial ligation. After the
abdomen was closed, the ligature was left in
place for 72 hr. Animals were killed five days
after religation of the left ureter and examined
for kidney infection and pyelonephritis as de-
scribed above.
Statistics. The differences observed in kidney
weights and the number of viable bacteria (du)/
g of kidney of treated and contn)1 animals were
compared for significance by Student's unpaired
t-test. Statistical comparison of the incidence of
sterilization between the treated groups was done
by the X2 method with Yates's correction.
Results
Bacterial killing by ampicillin and gentamicin
in vitro. As shown in figure I, the combination
of ampicillin and gentamicin was more effective
and more rapid in killing E. coli 06 (Williams)
than was either drug alone, a finding demon-
strating an in vitro synergistic effect. Among 12
fresh isolates of E. coli from human urine, results
almost identical to those in figure I were obtained
with I I strains. These I I strains were also killed
through the synergistic action of ampicillin and
10
9
-'
~B
a:
~ 5
~
::J4
z
23
o
a
-' 2
246
HOURS OF INCUBATION
Figure 1. Bacterial killing of Escherichia coli 06
(Williams) by ampicillin (AP) and gentamicin (GM).
Data are given as loglO number of cfu of E. coli 06
(Williams) found after exposure of the bacteria to various
concentrations (I-lg/ml; indicated on the curves) of AP,
GM, or a combination of the two drugs (AP + GM).
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o
Kidney condition after treatment for
Table 1. Comparison of the effect of therapy with a
single drug (ampicillin [Amp] or gentamicin [Gm]) with
that of therapy with the two antibiotics in combination on
the outcome of rat kidney infection due to Escherichia
coli 06 (Williams).
10 days5.5 days
Treatment Infected Sterile Infected Sterile
Gm 8 1 5t 4
Amp 13* 0 lOt 1
SumofGm
and Amp 21* 15t 5
Amp plus Gm
(combined) 3 6 0 8
More important, the combination of ampicil-
lin and gentamicin was more effective in steriliz-
ing kidneys than was either drug alone (P <
0.05; table 1). This was also seen if the sum of
the effect of each individual drug was compared
with the effect of therapy with the combined
drugs after 5.5 or 10 days. After 10 days, com-
bined therapy sterilized all kidneys. As early as
5.5 days after infection, when only one of eight
and none of 13 kidneys were sterilized by gen-
tamicin and ampicillin, respectively, treatment
with the combination of antibiotics sterilized
six of nine kidneys (not significant when com-
pared to treatment with gentamicin alone; P <
0.01 when compared to treatment with ampicillin
alone).
For further investigation of whether combined
therapy was effective because of an additive ef-
fect of each drug or because of a synergistic effect
of the combination, groups of 10 rats were treated
with double dosages of ampicillin (320 mg/kg
per day) for 5.5 and 10 days. The mean cfu
(± sn)/g recovered from these kidneys was similar
to that found after treatment with a single dos-
age of ampicillin (160 mg/kg per day): by 5.5
days of treatment, 3.0 ± 1.5 X 104 vs. 4.7 ± 2.6 X
103, respectively, and by 10 days, 1.2 ± 0.7 X 102
vs, 6.4 ± 6.7 X 10). There was no increased in-
NOTE. Data are number of rats. See Materials and Methods
for antibiotic dosages used. Statistical analyses were done with
the X' method with Yates's correction. Except as noted, relevant
comparisons were not significant.
• P ";0.05 compared with combined treatment for 5.5
days.
tP ";0.05 compared with combined treatment for 10
days.
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Figure 2. Effect of antibiotic treatment on rat kidney
infection. The data are given as loglo number of cfu
recovered/g of kidney after im treatment with ampicillin
(AP), gentamicin (GM), or a combination of the two (AP
+ GM). Therapy was begun 28~30 hr after infection with
Escherichia coli 06 (Williams) (day 0) and continued for
1.5, 3.5, 5.5, and 10 days. Each point represents the
mean value for determinations in nine to 14 rats. Control
animals received saline im. Statistical analysis for
significance was done with Student's unpaired z-test, and
the differences between therapy with different drugs were
as follows. After 1.5 days: AP vs. GM, AP vs. AP + GM,
and GM vs. AP + GM, P not significant. After 3.5 days:
AP vs. GM, P< 0.05; AP vs. AP + GM, P = 0.01; and
GM vs. AP + GM, P< 0.05. After 5.5 days: AP vs. GM,
P not significant; AP vs. AP + GM, P < 0.05; and
GM vs. AP + GM, P< 0.05. After 10 days: AP vs. GM,
P not significant; AP vs. AP + GM, P < 0.025; and
GM vs. AP + GM, P< 0.05.
gentamicin when examined by the method used
in figure 1.
Effect of treatment on kidney infection. Fig-
ure 2 shows the number of bacteria surviving in
the homogenates of left kidney tissue after treat-
ment of the rats for various intervals with ampi-
cillin and gentamicin either alone or in combi-
nation. The combination of ampicillin and gen-
tamicin was more effective than either drug alone;
the number of bacteria/g of kidney after treat-
ment for 3.5, 5.5, and 10 days with the combina-
tion of antibiotics was significantly lower than
with either drug alone. There was no difference
in the in vivo antimicrobial activity of ampicillin
or gentamicin except for a slightly greater activi-
ty of gentamicin at 3.5 days.
Antibiotic Synergism in Pyelonephritis
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Figure 3. Effect of antibiotic treatment for various intervals on the severity of pyelonephritis as measured by the ratio
of the weight of the left kidney to that of the right (L/R). N = L/R in normal rats; S = L/R in saline-treated controls;
A = L/R in ampicillin-treated rats; G = L/R in gentamicin-treated rats; A + G = L/R in rats treated with ampicillin
and gentamicin combined; and NP = no pyelonephritis, i.e., L/R in rats that did not develop pyelonephritis after ligation.
The brackets over each column indicate the 95% confidence limit.
cidence of sterile kidneys. If an additive effect of
ampicillin and gentamicin in combination were
likely, one might have expected that doubling the
dosage of a single drug (ampicillin) would have
resulted in a similar therapeutic advantage. As
this was not the case, the observation was there-
fore interpreted as an indirect argument for III
vivo synergy of ampicillin and gentamicin.
The bacteria surviving after treatment for 10
days with either ampicillin or gentamicin alone
were tested in several instances for acquired re-
sistance to antibiotics. No loss of sensitivity to
these antibiotics was demonstrated.
Effect of treatment on the severity of pyelone-
phritis. Both the degree of kidney infection
and the severity of renal lesions were profoundly
reduced by treatment. Figure 3 demonstrates the
effect of antibiotic treatment on the course of
the disease. By 3.5 days all three antibiotic regi-
mens significantly reduced the L/R ratios, al-
though gentamicin alone and the combination
of gentamicin and ampicillin were slightly but
significantly better than ampicillin alone (P <
0.0 I; table 2). After treatment for 5.5 and 10 days,
the mean L/R ratio of all treated animals was
not different from that of nonpyelonephritic con-
trols, and no difference between the three anti-
biotic regimens was observed.
Religation of the left ureter after therapy for
10 days. To evaluate the significance of the
small numbers of bacteria recovered from the
kidneys of antibiotic-treated rats, ureters were re-
ligated 36 hr after the completion of antibiotic
therapy, and bacteriologic studies were carried
out five days later. At the time of religation, the
kidneys were examined for macroscopic evidence
of pyelonephritis. In each experiment one group
of animals was studied bacteriologically at the
time of religation of the ureter in the test group.
Kidneys without macroscopic inflammatory le-
sions were sterile and remained so even after reli-
gation of the ureter.
Thirty-six hours after completion of treat-
ment, the pyelonephritic kidneys in eight rats
with lesions treated with ampicillin for 10 days
were cultured and had a mean count (± sn) of
46 ± 69 cfu, Religation of the ureter in 17 pyelo-
nephritic animals similarly treated resulted in a
recurrence of acute infection in 12 animals
(71%) five days later. The mean bacterial col-
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Table 2. Severity of pyelonephritis due to Escherichia coli 06 (Williams) in rats after treatment with antibiotics for 3.5
days.
Treatment
Saline (controls)
Animals without lesions·
Pyelonephritic animals
Gentamicin
Ampicillin
Ampicillin plus gentamicin
No. of rats
7
18
14
12
12
Mean L{R ratio ±SD
1.024 ±0.088
1.767 ± 0.242 }
1.041 ± 0.089t}
1.159 ± 0.126
0.984 ± 0.085 t}
Difference between
treatment groups
P<0.0005
P <0.01
P <0.0025
Difference from
pyelonephritic controls
0.726 (P <0.0005)
0.608 (P <0.0005)
0.783 (P <0.0005)
NOTE. See Materials and Methods for the dosages used in treatment of the rats with antibiotics. The severity 01 pyelonephritis in
the left kidney is expressed as the ratio of the mean weight of the left kidney to that of the right kidney (L/R). Statistical analysis for
significance was done with Student's unpaired t-test.
• Animals without lesions are those which did not develop pyelonephritis after ligation; the L/R ratio for this group is not significant-
ly different from that of rats treated with gentamicin or ampicillin plus gentamicin.
tDifference not significant.
ony count (± sn) was 3.0 ± 7.1 X 108 in the
relapsing kidneys (P < 0.0001 when compared
with controls killed at the time of religation).
Thus the small number of bacteria remaining in
the kidney after 10 days of ampicillin treatment
was pathogenic in the reobstructed kidney.
It was of considerable interest that 36 hr after
the completion of 10 days of gentamicin treat-
ment, five of nine rats with lesions showed in-
fection persisting in their pyelonephritic kidneys.
Small numbers of bacteria (48 ±66 cfu) were
also recovered, a finding comparable to the num-
ber recovered from the kidneys of ampicillin-
treated rats. In contrast to the ampicillin-treated
rats, however, religation of the ureter did not re-
kindle the infection, either morphologically or
bacteriologically, in eight rats with pyelonephri-
tis. Since gentamicin is known to accumulate and
persist in the kidney, this phenomenon was con-
sidered evidence of persistent antimicrobial ac-
tivity. This phenomenon has been examined in
detail and is the subject of a separate publica-
tion [18]. Because of this observation and because
pyelonephritic kidneys treated with combined an-
tibiotic therapy were all sterile, religation was
not studied after treatment of the rats with am-
picillin and gentamicin in combination.
Discussion
This study demonstrated that a combination of
antibiotics is superior to either drug alone in
the treatment of obstructive pyelonephritis when
the two drugs are synergistic in vitro against the
infecting organism. There is some evidence that
this advantage is due to an in vivo synergism rath-
er than to an additive effect because therapy with
the combination of ampicillin and gentamicin
was more effective than the sum of the effect of
the drugs administered singly and because doubl-
ing the dosage of a single drug did not improve
its efficacy in vivo.
Although evidence for the superiority of anti-
biotic combinations in vivo has been obtained in
experimentally induced infections when the com-
bination was synergistic in vitro [19-22], only
the studies of Sapico et al. [10] on hematogenous
enterococcal infection of the nonobstructed kid-
ney have demonstrated such superiority in the
treatment of pyelonephritis. McCabe and Jack-
son [23] found that among patients with pyelo-
nephritis, urine was sterile in 87% of those treat-
ed with a combination of antimicrobial agents
synergistic in vitro against the organism isolated
from the urine, in 67% when the combination
was additive, and in 14% when the combination
was antagonistic. Such results, however, are not
useful in judging the antimicrobial effect on the
kidney parenchyma since these patients suffered
frequent relapses [23].
The importance of sterilizing the infection in
the presence of urinary tract obstruction was
shown by the ease with which reinfection oc-
curred in rat kidneys containing as few as 40-50
residual bacterial cfu after treatment with am-
picillin.
Antibiotic Synergism in Pyelonephritis
The inability of small numbers of bacteria to
reinfect gentamicin-treated animals is interest-
ing and suggests that the known renal accumula-
tion of gentamicin is accompanied by persistent
antibacterial activity. If this is true, then this
phenomenon is unlikely to last since there is con-
tinuous elimination of the stored gentamicin by
the urine [13], thus emphasizing the need for ster-
ilization.
Gentamicin was slightly superior to ampicillin
in the eradication of bacteria after treatment for
3.5 days and was as effective as ampicillin after
5.5 and 10 days of treatment, even though gen-
tamicin was administered only two times in 24
hr compared with four times in 24 hr for ampi-
cillin. These observations provide additional evi-
dence that accumulation and persistence of gen-
tamicin in the renal parenchyma [13] are respon-
sible for the therapeutic advantage of this drug
over an antibiotic that does not accumulate in the
treatment of renal parenchymal infection.
This study also demonstrated that antibiotic
treatment not only affects the number of bacteria
but also reduces the severity of renal inflamma-
tion as determined by a significant decrease in
the LjR ratios. The ability of antibiotics to in-
hibit suppuration was as evident 5.5 or 10 days
after treatment with a single drug as it was with
the combination of antibiotics. In other words,
the in vivo superiority of the antimicrobial com-
bination was not expressed as an anti-inflamma-
tory advantage, presumably because the bacterial
load after therapy with a single drug was below
the suppurative level.
These observations of the rat model system
show that sterilization of obstructive pyelonephri-
tis is best achieved with a combination of anti-
biotics that is synergistic in vitro. Many strains of
Pseudomonas [19] and Proteus mirabilis [24] are
susceptible to synergistic inhibition by penicil-
lin and aminoglycoside antibiotics. Using the
technique described for testing E. coli 06 (Wil-
liams), we found that II of 12 strains of E. coli
isolated from the urine of patients were syner-
gistically killed by ampicillin and gentamicin.
This synergism could be of importance in the
treatment of patients with obstructive pyelone-
phritis in whom prevention of relapse depends
upon sterility.
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